Corporate Greed Case Study: Dentsply Sirona’s Byte & Its Impact on Consumers

TLDR: A class-action lawsuit alleges that dental giant Dentsply Sirona and its subsidiary, Byte, marketed and sold at-home teeth aligners to consumers with the promise of a safe, affordable, and “doctor-directed” path to a perfect smile. Instead, the company is accused of knowingly selling a dangerous and ineffective product that led to hundreds of severe adverse health events, including bone loss, dead teeth, and permanent jaw damage. After raking in profits by targeting financially vulnerable customers, the company itself admitted its patient safety protocols were inadequate, leaving customers with physical pain and financial loss.

For a deeper look into the deception and the systemic failures that enabled it, continue reading below.

Introduction: The High Price of an “Affordable” Smile

The promise was tantalizingly simple and modern: a perfect smile without the high cost and inconvenience of traditional orthodontics. Straight Smile LLC, operating as Byte, and its parent company, the dental behemoth Dentsply Sirona, built a billion-dollar business on this premise. Their advertising, which claimed, “At Byte, we believe in making the inaccessible, accessible,” presented a direct-to-consumer solution for anyone dreaming of a confident, straight smile.

This marketing narrative, however, conceals a story of significant harm.

A class-action lawsuit filed in Florida paints a disturbing picture of corporate practices that prioritized profits over patient safety.

The legal complaint argues that Byte’s teeth aligner systems, far from being the safe and effective treatment promised, were dangerous products associated with hundreds of severe medical complications, knowingly sold to the public through a campaign of deceptive representations. This case is more than a dispute over a single product; it is an examination of a business model that targets vulnerable populations and illustrates the profound public health consequences that can arise in a market that prizes disruption over diligence.

Inside the Allegations: A Pattern of Deception and Harm

The core of the lawsuit rests on the steep contrast between Byte’s marketing and the actual reality of its products. The company heavily promoted its aligners as being “Doctor directed,” assuring customers that their “treatment plan is reviewed and prescribed by a dentist.” This created the powerful impression that despite being an at-home kit, each customer’s journey was guided by the same professional standards found in a traditional orthodontist’s office.

These representations are described in the legal filing as materially false and misleading. The complaint states that the products lacked sufficient oversight from medical professionals. This failure is linked directly to a litany of harrowing health consequences suffered by customers.

Reported Adverse Health Events Associated with Byte Aligners

Category	Specific Complications
Tooth & Bone Damage	Bone loss, breaking and chipping of teeth, loosening of teeth, pulp necrosis (dead tooth), tooth fracture, tooth discoloration
Bite & Jaw Issues	Bite misalignment, severe open bite, worsening of patient bite, jaw clicking, locked jaw
Gum & Mouth Trauma	Cutting of gums, gum recession, facial swelling, abscess in mouth, periodontal disease
Product Safety	Allergic reactions, choking on aligners due to poor fit

The lawsuit points to a federal agency’s publicly available database, which contains at least 500 adverse event reports associated with the Byte Aligner from October 2020 onward. The plaintiff in the case, Paula J. Phillips, a Florida resident, provides a firsthand account of the harm. After purchasing the Byte system for $3,338.02, she began using the product as instructed. Within a month, she started experiencing pain and bleeding in her mouth, which grew so severe she had to stop the treatment entirely. When she sought a refund, she was informed that none was available.

This pattern of harm culminated in the company’s own stunning admissions. The lawsuit details a series of events that suggest the company knew its processes were flawed long before it took action.

Timeline of a Corporate Crisis

Date	Event
December 31, 2020	Dentsply Sirona acquires Straight Smile LLC (Byte) for $1.04 billion in an all-cash deal.
October 2020 – October 2024	Hundreds of adverse events involving the Byte Aligner product are reported.
October 30, 2020 – December 27, 2023	Over 175 adverse events are reported, including many of the same conditions the company would later warn about.
April 18, 2024	Plaintiff Paula J. Phillips purchases the Byte Aligner System.
June 2024	Ms. Phillips begins experiencing pain and bleeding from using the product and stops treatment.
October 24, 2024	Dentsply Sirona announces it is suspending sales of Byte products to conduct a “review of certain regulatory requirements.”
October 25, 2024	Byte posts an “Important Message for Patients,” admitting its “patient onboarding workflow may not provide adequate assurance that certain contraindicated patients do not enter treatment.”
February 12, 2025	Ms. Phillips learns of the company’s statements and requests a full refund. None is paid.
March 7, 2025	A class-action complaint is filed against Straight Smile LLC and Dentsply Sirona Inc.

Even after halting new orders, the company’s website continued to promote the aligners with slogans like “ALIGN WITH CONFIDENCE,” creating further confusion for consumers. The company’s “Important Message” advised patients to visit a dentist for a health review, an admission that directly undermines the product’s core promise of avoiding costly in-office appointments.

Regulatory Loopholes and Corporate Accountability

The case against Byte and Dentsply Sirona highlights a critical failure in corporate self-regulation and external oversight. The lawsuit claims that the victims “lacked essential feedback loops to timely advise regulators” about the recurring adverse events associated with their products. This suggests a system where consumer complaints and reports of injury were not adequately channeled to the government bodies responsible for ensuring product safety.

This breakdown in reporting is a hallmark of corporate structures that operate in legal and regulatory gray zones. The direct-to-consumer model, while innovative, bypasses traditional checkpoints in the healthcare system. Without the mandatory in-person consultation, the responsibility for identifying at-risk patients fell entirely on the company’s remote “onboarding workflow,” a system that Byte itself eventually admitted was inadequate.

The company’s announcement of a “review of certain regulatory requirements” on October 24, 2024, is presented in the lawsuit as an admission of this failure. It implies that for years, while hundreds of customers were being harmed, the company may have been operating without full adherence to the necessary safety and regulatory standards. The lawsuit contends that this was not an accidental oversight but a feature of a business model designed to minimize costs and maximize reach, leaving public safety as an afterthought.

Profit-Maximization at All Costs

The financial incentives driving Byte’s business model are central to the allegations. Dentsply Sirona’s acquisition of Byte for $1.04 billion demonstrates the immense market value placed on the company’s direct-to-consumer approach. The lawsuit argues that this pursuit of profit came at the expense of consumer health and safety. The entire enterprise was predicated on cutting out the most critical, and most expensive, part of orthodontic treatment: the in-person care of a licensed professional.

This strategy was coupled with a marketing campaign that deliberately targeted financially vulnerable populations. The company’s website proclaimed, “A straighter smile was once only reserved for certain groups of people. We set out to change that, to democratize oral healthcare.” The lawsuit reframes this message not as a noble mission of accessibility, but as a calculated strategy to exploit a demographic with fewer healthcare options. By positioning itself as an affordable alternative, Byte attracted customers who were more likely to trust its claims and less likely to be able to afford corrective dental work if something went wrong.

The defendants’ public filings with the Securities and Exchange Commission repeated these assurances of safety and oversight. The company told investors it contracted with a “nationwide network of independent licensed dentists and orthodontists” to ensure proper clinical oversight. The lawsuit claims these were misleading statements designed to maintain investor confidence and project an image of legitimacy while the product was causing widespread harm.

The Economic Fallout for Consumers

The financial consequences of Byte’s corporate misconduct fall squarely on its customers. The lawsuit seeks to recover damages for a class of consumers who paid thousands of dollars for a product that was not only ineffective but dangerous. The lead plaintiff, Paula Phillips, lost $3,338.02 on a product that she claims caused her physical injury. With the lawsuit seeking over $5 million in aggregate damages, the economic toll on the class of Florida purchasers is substantial.

Beyond the initial purchase price, consumers are now facing additional, unforeseen costs. Byte’s own recommendation that customers should “visit a dentist to review your overall oral health” represents a significant financial burden. These are precisely the costs the product was advertised to help consumers avoid. For customers who suffered adverse effects, the economic fallout is even more severe, including the high cost of dental and medical treatments to repair damage caused by the aligners.

This situation exemplifies the economic principle of externalizing costs. The company reaped the profits from its low-overhead business model, while its customers were left to bear the financial and physical costs of its failure. The lack of a refund policy for a product pulled over safety concerns further compounded the economic injury, trapping consumers in a financial loss even after the product proved harmful.

A Systemic Public Health Threat

The allegations against Byte and Dentsply Sirona transcend a simple case of product liability; they describe a systemic threat to public health. The lawsuit explicitly states the company sold products that were “not safe for human use” and continued to do so even after it should have known about the serious risks. The wide range of severe medical complications reported, from bone loss to locked jaws, indicates a fundamental flaw in the product’s design or application.

The business model itself created a public health risk by removing the established safeguards of professional medical care. Traditional orthodontics involves X-rays, physical examinations, and regular monitoring to prevent the very complications that Byte’s customers suffered. By replacing this rigorous process with an at-home impression kit and a remote, algorithm-driven treatment plan, the company introduced a product into the national market that was ill-equipped to handle complex dental issues.

The company’s own “Important Message for Patients” from October 2024 belatedly acknowledged that the aligners were contraindicated for patients with a number of serious dental conditions, such as “active periodontal disease, severe open bite,” or those with dental implants. The lawsuit argues that the company’s screening process was deficient and failed to prevent such patients from using the product, leading directly to their injuries. This was a foreseeable failure, and one that placed the public’s health at risk for the sake of market share and revenue.

Exploitation of Workers

While the legal filing against Dentsply Sirona and Byte focuses squarely on the harm inflicted upon consumers, the corporate mindset it describes is part of a much larger economic story. The relentless drive to cut costs and maximize profits, which led to a dangerous product, is the same logic that frequently results in the exploitation of labor in a neoliberal capitalist system. A business model predicated on bypassing professional labor (in this case, in-person orthodontists) to reduce expenses often reflects a broader corporate strategy where the workforce is seen as a cost to be minimized rather than a resource to be valued.

In this economic framework, a company’s treatment of its customers and its workers are two sides of the same coin. The prioritization of shareholder value over human well-being does not stop at the factory door or the customer service desk. While the complaint does not detail Byte’s internal labor practices, the external behavior—extracting maximum value from consumers while providing a product of minimal quality and safety—is consistent with corporate structures that also suppress wages, limit benefits, and fight unionization to achieve similar financial goals at the expense of their employees.

Community Impact: Undermining a Community of Trust

The community harmed by Byte’s evil actions is not defined by geography but by a shared vulnerability. The lawsuit makes clear that the company targeted a community of financially disadvantaged consumers, a group often excluded from or underserved by the traditional healthcare system. By promising an affordable and accessible path to a better smile, the company tapped into the powerful desire for self-improvement and social acceptance within this community.

The impact of the company’s utter failure extends far beyond individual financial loss and physical pain. It represents a profound betrayal of trust that poisons the well for future innovations aimed at improving healthcare access. When a company uses the language of “democratizing” healthcare to market a product that causes harm, it breeds cynicism and fear, particularly among the very communities that have the most to gain from legitimate, safe, and affordable alternatives. The damage, therefore, is also to the social fabric, eroding confidence that the market can or will provide safe solutions for those who need them most.

The PR Machine: Corporate Spin as a Weapon

The lawsuit methodically deconstructs the public relations and marketing apparatus that Byte used to build its brand and gain consumer trust. The company’s representations were not merely advertisements; they were a carefully crafted narrative of legitimacy and safety. The repeated claim of being “Doctor directed” was the cornerstone of this strategy, designed to neutralize the obvious concern about an at-home medical treatment.

This was bolstered by what the lawsuit refers to as the company’s claims of being “FEATURED IN” prominent publications like Forbes, InStyle, and even Harvard Medical School. This tactic, known as reputation laundering, uses the credibility of established institutions to create a halo effect around a product. By associating its brand with respected names, Byte built a veneer of trustworthiness that could persuade a customer to overlook the inherent risks. The lawsuit argues that this entire public-facing image was a deceptive fiction, a form of corporate spin designed to sell a product that could not stand on its own merits.

Wealth Disparity and Corporate Greed

At its core, the Byte lawsuit is a story about wealth disparity and the mechanics of modern corporate greed. The transaction that brought Byte into the Dentsply Sirona portfolio—a $1.04 billion all-cash deal—reveals the immense financial value that Wall Street places on business models that successfully tap into lower-income markets. The lawsuit contends that this value was created by extracting money from a less affluent consumer base in exchange for a defective and dangerous product.

This dynamic is a classic feature of late-stage capitalism, where wealth flows upward from the many to the few. The profits generated from the sale of thousands of aligner kits did not primarily benefit the customers or result in a higher-quality product. Instead, they enriched the corporate parent, Dentsply Sirona, and its shareholders. The refusal to issue refunds is a brilliant illustration of this principle; even after the product failed and caused harm, the company’s imperative was to retain the revenue it had collected. The system is designed to protect the accumulated capital, not the well-being of the consumer who provided it.

Global Parallels: A Pattern of Predation

The business model described in the Byte lawsuit is not unique to the dental industry. It is a playbook that has been deployed across numerous sectors in the global economy, particularly those “disrupted” by tech platforms. The strategy is consistent: identify a regulated industry, create a lower-cost, direct-to-consumer alternative that bypasses traditional safeguards, use aggressive marketing to promise accessibility and empowerment, and shift the risk onto the end user.

This pattern is visible in the gig economy, where transportation and delivery companies frame themselves as liberating workers while classifying them as contractors to avoid providing benefits and protections. It appears in the fintech industry, where apps offer easy loans at high interest rates, bypassing the consumer protections of traditional banking. In each case, the language of innovation and “democratization” is used to mask a business model based on regulatory arbitrage and the exploitation of a perceived market inefficiency, with the public often bearing the ultimate cost.

Corporate Accountability Fails the Public

The very existence of this class-action lawsuit demonstrates a catastrophic failure of the systems designed to ensure corporate accountability. The primary lines of defense for public health—internal corporate ethics and external government regulation—appear to have broken down. According to the complaint, Byte and Dentsply Sirona failed to act on hundreds of adverse event reports and lacked the basic feedback loops to inform regulators, forcing harmed consumers to seek justice through complex, expensive, and slow-moving litigation.

This is a reactive, not proactive, form of accountability, and it is woefully inadequate. Even if the lawsuit is successful, the most likely outcome is a financial settlement and a court order to halt certain practices. Such penalties are often treated by large corporations as a mere cost of doing business, a rounding error on a balance sheet that boasts billion-dollar valuations. The framework of corporate law itself, which shields executives from personal liability in most cases, ensures that the individuals who made the key decisions rarely face meaningful consequences, leaving the system of corporate impunity largely intact.

Pathways for Reform and Consumer Advocacy

The failures alleged in the Byte lawsuit point directly to clear and necessary pathways for reform. To prevent similar public health issues in the future, regulators must strengthen their oversight of the rapidly growing direct-to-consumer medical device market. This includes enforcing strict standards for what can be marketed as “doctor-directed” or “doctor-prescribed,” ensuring the terms reflect genuine, substantive clinical oversight, not just a useless rubber stamp.

Furthermore, there must be mandatory, transparent, and rapid reporting of all adverse events, with severe financial and legal penalties for companies that fail to comply. The creation of a publicly accessible and easily searchable database of these events would empower consumers and advocacy groups to identify dangerous products far more quickly. Finally, strengthening the power of agencies like the FDA and FTC to issue immediate stop-sale orders and mandate refunds for products found to be unsafe would shift the balance of power away from corporations and back toward the public they are meant to serve.

Legal Minimalism: Doing Just Enough to Stay Plausibly Legal

The corporate behavior detailed in the complaint exemplifies the principle of legal minimalism, a common strategy in late-stage capitalism. This approach involves complying with the letter of the law in the most superficial way possible, while completely ignoring its spirit and intent. The goal is not to ensure safety or efficacy, but to create a defensible legal position in the event of a lawsuit.

Byte’s claim of having a network of dentists to review cases, which the lawsuit alleges was insufficient, is a perfect illustration of this. The company created the appearance of medical oversight, allowing it to legally market the product as “doctor-directed.” However, the sheer volume of injuries suggests this oversight was a procedural fiction rather than a substantive safeguard. The company’s decision to review “certain regulatory requirements” only after years of sales and hundreds of injuries further suggests a corporate culture that viewed regulation not as a moral baseline for safety, but as a checklist to be managed.

How Capitalism Exploits Delay: The Strategic Use of Time

Time is a strategic weapon in a capitalist system, and the timeline presented in the Byte lawsuit shows how it can be exploited for profit. The complaint claims that from October 2020 to October 2024, hundreds of incidents involving adverse events were reported. For four years, while these reports accumulated, the company continued to market and sell its product, generating revenue every single day.

Each day of delay in taking action—whether by recalling the product, changing the marketing, or halting sales—was another day of profit. In a system that incentivizes quarterly earnings and shareholder returns, the future cost of potential litigation can seem abstract and distant compared to the concrete reality of present-day revenue. This calculation encourages a form of corporate inertia, where problems are not addressed until they become a legal or public relations crisis. This strategic use of delay ensures that even when a company is eventually held to account, it has already extracted the maximum possible profit from the harmful activity.

The Language of Legitimacy: How Corporations Frame Harm

In the world of corporate marketing, language is a tool used to construct reality. The lawsuit against Byte and Dentsply Sirona provides a masterclass in how corporations use the language of legitimacy to obscure risk and project safety. The term “doctor-directed” is the most potent example, a carefully chosen phrase that sounds authoritative and reassuring while being legally ambiguous enough to defend. It suggests the active involvement of a personal physician, when the reality in the legal complaint was a remote, impersonal, and inadequate review process.

This use of technocratic and professional language serves to neutralize consumer anxiety. When Byte stated in SEC filings that it uses a “nationwide network of independent licensed dentists and orthodontists for the provision of clinical services,” it was speaking to investors and the public in the formal language of compliance. The lawsuit argues this language created a smokescreen, allowing the company to operate its high-risk, low-oversight model behind a facade of professional legitimacy. This is how harm is framed in neoliberal systems—not as a human consequence, but as a manageable variable described in sanitized, corporate-approved terms.

Monetizing Harm: When Victimization Becomes a Revenue Model

A particularly distressing feature of the economic system described in the lawsuit is its ability to monetize harm itself. When a customer, like the plaintiff Paula Phillips, pays thousands of dollars for a product that causes injury, and is then denied a refund, the company has successfully converted that customer’s suffering into retained revenue. The $3,338.02 paid by Ms. Phillips was not returned, meaning the company profited not just from the sale, but from her inability to get her money back after the product failed her.

This is not an anomaly; it is an outcome of a business model that prioritizes cash flow above all else. By making refunds difficult or impossible to obtain for a medical product, the company ensures a steady stream of income regardless of the outcome for the patient.

This transforms customer dissatisfaction and even injury into a predictable part of the profit-and-loss statement. In this model, the consumer’s loss is the corporation’s gain, turning the very act of victimization into a source of secure revenue.

Profiting from Complexity: When Obscurity Shields Misconduct

The corporate structure at the heart of this lawsuit is, in itself, a tool for managing risk and obscuring responsibility. The product is sold by “Straight Smile LLC d/b/a Byte,” but this entity is wholly owned by Dentsply Sirona Inc., a global dental supply conglomerate. This parent-subsidiary structure, a hallmark of modern capitalism, allows the parent company to profit from a high-risk, high-reward venture while maintaining a degree of brand separation.

This corporate opacity serves to diffuse accountability. If the subsidiary venture fails or becomes mired in scandal, the parent company’s broader reputation is partially shielded. It allows a large, established corporation like Dentsply Sirona to engage in the “disruptive” and aggressive tactics of a startup like Byte without directly tainting its core brand. For the consumer, this complexity makes it harder to understand who is truly responsible, creating a labyrinth of corporate entities that deflects liability and protects the ultimate beneficiaries of the profit.

This Is the System Working as Intended

It is tempting to view the story of the Byte aligner as a case of a good system failing. The evidence presented in the lawsuit, however, supports a more troubling conclusion: this is the system working exactly as it was designed. A capitalist framework that structurally prioritizes profit maximization will inevitably produce companies that cut corners on safety to reduce costs and increase market share.

The targeting of financially vulnerable consumers is the whole literal feature of our economic system that seeks out untapped markets to exploit.

The use of deceptive marketing is a logical outcome of an environment where perception is more profitable than reality. The $1.04 billion acquisition of Byte by Dentsply Sirona is perhaps the most compelling evidence of all.

It shows that the system does not punish this behavior; it rewards it with a massive influx of capital. The harm to consumers is not an aberration, but a predictable externality in an economic model that has been optimized for corporate profit above all else.

Conclusion: The Human Cost of a Corporate Gamble

The class-action lawsuit against Straight Smile LLC and Dentsply Sirona is more than a legal dispute over a dental product. It is a brutal illustration of the human cost of unchecked corporate ambition operating within a deregulated market.

The legal complaint methodically lays out a story of a corporate giant that saw an opportunity to profit from the hopes of people desiring a better smile and exploited that desire with a product that was dangerously under-supervised. The promise of an affordable, accessible dream became, for many, a nightmare of physical pain, financial loss, and shattered trust.

This case serves as a powerful reminder that behind the marketing slogans, SEC filings, and billion-dollar valuations are real people. The legal battle of Paula Phillips and the class she represents highlights the deep and systemic failures that occur when the well-being of the public is subordinated to the relentless pursuit of profit. It reveals a fundamental conflict in our modern economy, one that pits the safety and dignity of the individual against a corporate structure designed to protect itself and its shareholders, no matter the human cost.

Frivolous or Serious Lawsuit?

Based on the detailed and specific allegations laid out in the legal complaint, this lawsuit represents a meaningful and serious legal grievance. The filing is not based on vague dissatisfaction, but on concrete claims of physical harm and financial injury, supported by a clear timeline of events and direct quotes from the defendants’ own marketing materials and public statements. The complaint’s reference to a federal database containing hundreds of similar adverse event reports suggests the plaintiff’s experience is part of a widespread pattern.

Crucially, the defendants’ own public admission on October 25, 2024—stating their “patient onboarding workflow may not provide adequate assurance that certain contraindicated patients do not enter treatment”—lends significant credibility to the core of the plaintiff’s argument.

This is not a frivolous claim; it is a substantive challenge to a billion-dollar enterprise, alleging a grievous breach of trust and a reckless disregard for public safety. It represents a legitimate attempt to hold a powerful corporate entity accountable for the consequences of its actions.

💡 Explore Corporate Misconduct by Category

Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.

• 💀 Product Safety Violations — When companies risk lives for profit.
• 🌿 Environmental Violations — Pollution, ecological collapse, and unchecked greed.
• 💼 Labor Exploitation — Wage theft, worker abuse, and unsafe conditions.
• 🛡️ Data Breaches & Privacy Abuses — Misuse and mishandling of personal information.
• 💵 Financial Fraud & Corruption — Lies, scams, and executive impunity.